The stock of Elanco Animal Health Inc (NYSE:ELAN) last traded at $13.46, up 4.10% from the previous session.
ELAN stock price is now -13.62% away from the 50-day moving average and 3.45% away from the 200-day moving average. The market capitalization of the company currently stands at $6.64B.
With the price target enhanced from $13 to $20, Stifel Upgraded its rating from Hold to Buy for Elanco Animal Health Inc (NYSE: ELAN). On December 19, 2023, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $17, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, DOYLE WILLIAM F, Director bought 15,000 shares of the company’s stock on Mar 08 ’24. The stock was bought for $244,500 at an average price of $16.30. Upon completion of the transaction, the Director now directly owns 61,330 shares in the company, valued at $0.83 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 08 ’24, Director Harrington Michael J bought 3,100 shares of the business’s stock. A total of $50,494 was incurred on buying the stock at an average price of $16.29. This leaves the insider owning 77,594 shares of the company worth $1.04 million. A total of 0.97% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $7.88 and a high of $16.88. As of last week, the company has a debt-to-equity ratio of 0.95, a current ratio of 2.75, and a quick ratio of 1.35.
The net profit margin was -27.87% and return on equity was -18.22% for ELAN. The company reported revenue of $1.03 billion for the quarter, compared to $984.0 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.18 percent.
